curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR

by palligoelme@gmail.com | Mar 25, 2026 | Clinical Trials

​ Conditions: Intraluminal Thrombosis; Tevar; FET Sponsors: Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico Not yet recruiting Conditions: Intraluminal Thrombosis; Tevar; FET Sponsors: Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico...

Evaluation of the Magnesium Shield Compared to Dual Zone Grafting Approach in Immediate Implant Site Management.

by palligoelme@gmail.com | Mar 25, 2026 | Clinical Trials

​ Conditions: Immediate Implant Placement Interventions: Device: GBR surgery using magnesium Shield; Procedure: Dual Zone concept (DZ) technique Sponsors: British University In Egypt Recruiting Conditions: Immediate Implant Placement Interventions: Device: GBR surgery...

Indigenous Nutritional Supplements for Pregnancy to Improve Resilience in Environmental Heat

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Heat Stress; Pregnancy; Women of Reproductive Age; Nutrition Status Interventions: Dietary Supplement: Indigenous Balanced Diet Arm Sponsors: Aga Khan University; Bill and Melinda Gates Foundation Not yet recruiting Conditions: Heat Stress; Pregnancy;...

Comparison of One-Step and Two-Step Light Curing of Bonding Agents and Composite in Orthodontics

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Orthodontic Treatment; Bracket Failure Interventions: Procedure: One step light curing of bonding agent and composite; Procedure: Two step light curing of bonding agent and composite Sponsors: Shaheed Zulfiqar Ali Bhutto Medical University...

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Chronic Heart Failure Interventions: Biological: MTP-101-C encapsulated Microbiota; Drug: Vancomycin; Drug: Neomycin Sponsors: Melana Yuzefpolskaya, MD Recruiting Conditions: Chronic Heart Failure Interventions: Biological: MTP-101-C encapsulated...
« Older Entries
Next Entries »

Recent Posts

  • Development and Clinical Evaluation of a Novel Hollow Cusp Fracture Reducer for Femoral Shaft and Patellar Fractures
  • Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
  • The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents – the PpUF-study.
  • Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
  • [Trial of device that is not approved or cleared by the U.S. FDA]

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®